iURO Oncology for iOS

Used iURO Oncology for iOS? Share your experience and help other users.

Developer’s Description

iURO Oncology is the must-have app for all uro-oncology healthcare professionals and students. The narrated simulation videos make it easy to...

iURO Oncology is the must-have app for all uro-oncology healthcare professionals and students. The narrated simulation videos make it easy to understand and explain the different pathologies and therapies. It can be used by doctors and nurses to enhance communication with their patients. Medical students can use iURO apps to increase their knowledge and understanding of various urological and oncological topics.iURO Oncology can also be used by patients directly, to familiarize themselves with the different aspects of their oncological condition and the treatment options available.Features include:Narrated simulation videos to explain prostate cancer, kidney cancer, bladder cancer and testicular cancerNarrated simulation videos to explain different treatment optionsDraw on picture, offering the opportunity to draw on and make personalized notes on a 3D image Send this customized 3D image directly to patients or colleagues by email 360 image of the kidney, offering the opportunity to zoom on the 3D image from every angle iURO apps are created in consultation with urologists in order to provide a realistic representation of pathologies and therapies. iURO apps are prepared with the aim of enhancing communication and education options. If you are not a healthcare professional, please note that iURO apps support but never substitute the relation with your healthcare professional. App Management: Scientific Director: Carlos Rioja, Hospital Royo Villanova, Zaragoza, Spain Scientific Director: Jorge Rioja, Hospital Miguel Servet, Zaragoza, Spain Scientific Director: Sanjeev Bandi, Mackay Urology, Mackay Australia iURO Scientific Advisory Board: Lithiasis Olivier Traxer, University Pierre et Marie Curie Paris, France Adrian Joyce, Spire Leeds Hospital in Roundhay, Leeds, Yorkshire, United Kingdom Benign Prostatic Hyperplasia Jean de la Rosette, AMC University Hospital, Amsterdam, The Netherlands Matthias Oelke, Hanover Medical School, Hanover, Germany Pelvic Floor Disorder, Functional and Female Urology David Castro, University of La Laguna, Tenerife, SpainDirk De Ridder, Kliniekhoofd Urologie UZ, Leuven, Belgium Oncology Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, USA Raul Parra, Memorial Sloan Kettering Cancer Center, New York, USA Peter Scardino, Memorial Sloan Kettering Cancer Center, New York, USA Pilar Laguna, AMC University Hospital, Amsterdam Sharokh Shariat, Weill Medical College of Cornell University, New York, USA Theo de Reijke, AMC University Hospital Amsterdam, The Netherlands Octavio Castillo Cadiz, Clnica Indisa, Santiago, Chile Jaime Landman, University of California Irvine, Los Angeles, USAAndrology Eduard Garcia, University Hospital Clcic de Barcelona, Barcelona, Spain Juan Ignacio Martinez Salamanca, University Hospital Puerta de Hierro Majadahonda, Autonomous University of Madrid, Madrid, Spain Ignacio Moncada, Hospital La Zarzuela, Madrid, Spain David J Ralph, St Peters Andrology Centre, London, United Kingdom Nelson Bennett, Lahey Hospital and Medical Center, Burlington, USARados Djinovic, Sava Perovic Foundation, Belgrade, Serbia